[{"Assets_0_Q1_USD":1328025000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.2,"EarningsPerShareBasic_1_Q1_USD":-0.16,"EarningsPerShareDiluted_1_Q1_USD":-0.16,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":15298000.0,"NetIncomeLoss_1_Q1_USD":-4545000.0,"StockholdersEquity_0_Q1_USD":575522000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":27867000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":27867000.0,"Ticker":"CNMD","CIK":"816956","name":"CONMED CORP","OfficialName":"CONMED Corporation Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4404922313.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20170427"}]